AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Hyperdiluted Calcium Hydroxylapatite: Applications in Treating Volume Loss and Skin Laxity

Description

The presentation discusses the use of hyperdiluted Calcium Hydroxylapatite (Kaha) in treating volume loss and skin laxity, particularly among aging patients. The speaker shares a case of a 52-year-old woman experiencing notable facial volume loss and laxity, emphasizing the importance of assessing the functional line of ligaments during treatment planning. Kaha, combined with CMC (carboxymethyl cellulose), enhances dermal support by stimulating collagen and elastin production, offering advantages in restoring youthful appearance without the risk of 'puffy' faces. The speaker highlights the efficacy of Kaha+CMC over traditional hyaluronic acid fillers, particularly in its ability to increase collagen type I. Injection techniques, including both standard and hyperdiluted methods, are explained along with the product's FDA approvals for multiple applications, such as skin rejuvenation of hands and décolletage. Case studies demonstrate the long-term benefits of Kaha in improving skin elasticity and texture, paired with solid recommendations from existing literature. The speaker stresses the need for safe administration and awareness of potential complications, concluding by reaffirming the significant advantages of Kaha for facial rejuvenation in cosmetic dermatology.

View more

Conclusions

  • Calcium Hydroxylapatite (CaHA) combined with Carboxymethyl Cellulose (CMC) can enhance skin quality and treat volume loss and skin laxity effectively in both facial and body applications.
  • CaHA/CMC fillers are versatile and facilitate personalized treatment options that align with the trend towards natural aesthetics.
  • Histopathological studies indicate that CaHA/CMC stimulates increased collagen and elastin production, leading to significant improvements in skin firmness and quality.
  • The combination of CaHA and CMC shows distinct advantages over traditional Hyaluronic Acid (HA) fillers in terms of biostimulation and long-term results.
  • Different dilution strategies can optimize the treatment based on individual patient needs, with recommendations for hyperdilution for broader coverage.
  • The safety profile of CaHA/CMC is robust, showing minimal adverse events when administered correctly and without complications such as granulomas or severe reactions.
  • Clinical evidence supports the strong recommendation of CaHA/CMC for treating facial and body volume loss, making it a top choice for dermatological practices.
  • Braz A, Palermo E, Issa MC. Revisiting the Ligament Line of the Face: A New Understanding for Filling the Fixed and Mobile Face. Dermatol Clin. 2024 Jan;42(1):97-102.
  • Goldie K, et al. Skin Quality - A Holistic 360º View: Consensus Results. Clin Cosmet Investig Dermatol. 2021 Jun 14;14:643-654.
  • Guida S, Galadari H. A systematic review of Radiesse/calcium hydroxylapatite and carboxymethylcellulose: evidence and recommendations for treatment of the face. Int J Dermatol. 2024 Feb;63(2):150-160.
  • Aguilera SB, McCarthy A, Khalifian S, Lorenc ZP, Goldie K, Chernoff WG. The Role of Calcium Hydroxylapatite (Radiesse) as a Regenerative Aesthetic Treatment: A Narrative Review. Aesthet Surg J. 2023 Sep 14;43(10):1063-1090.
  • Yutskovskaya Y, et al. A Randomized, Split-Face, Histomorphologic Study Comparing a Volumetric Calcium Hydroxylapatite and a Hyaluronic Acid-Based Dermal Filler. J Drugs Dermatol. 2014; 13(9):p1047-1052.
  • Kunzler C, Hartmann C, Nowag B, Shah R, El-Banna R, Backfisch S, Schafer D, Hengl T, Hagedorn N. Comparison of Physicochemical Characteristics and Biostimulatory Functions in Two Calcium Hydroxyapatite-Based Dermal Fillers. J Drugs Dermatol. 2023 Sep 1;22(9):910-916.
  • Yutskovskaya YA, Kogan EA, Koroleva AY, Galadari HI. Comparative Clinical and Histomorphologic Evaluation of the Effectiveness of Combined Use of Calcium Hydroxyapatite and Hyaluronic Acid Fillers for Aesthetic Indications. Dermatol Clin. 2024 Jan;42(1):103-111.
  • Rovatti L, Pellacani G, Guida S. Dermatol Surg. 2020;
  • Yutskovskaya YA, Kogan EA. Improved neocollagenogenesis and skin mechanical properties after injection of diluted Calcium hydroxyapatite the neck and décolletage: a pilot study. J. Drugs Dermatol. 2017 Jan 1;16(1): 68-74.
  • Guida S, Longhitano S, Spadafora M, Lazzarotto A, Farnetani F, Zerbinati N, Pellacani G, Galadari H. Hyperdiluted calcium hydroxylapatite for the treatment of skin laxity of the neck. Dermatol Ther. 2021 Sep;34(5):e15090.
  • Goldie K et al ., Dermatol Surg 2018;44:S32-S41.
  • Pavicic T. Calcium hydroxylapatite filler: an overview of safety and tolerability. J Drugs Dermatol. 2013 Sep; 12(9): 996-1002.
  • Carruthers A, Liebeskind M, Carruthers J, Forrester BB. Radiographic and Computed Tomographic Studies of Calcium Hydroxylapatite for Treatment of HIV-Associated Facial Lipoatrophy and Correction of Nasolabial Folds. Dermatol Surg. 2008 Jun; 34: p78-84.
  • Tzikas TL. A 52-month summary of results using calcium hydroxylapatite for facial soft tissue augmentation. Dermatol Surg. 2008 Jun; 34 Suppl 1: p9-15.
  • Sadick NS, Katz BE, Roy D. A multicenter, 47-month study of safety and efficacy of calcium hydroxylapatite for soft tissue augmentation of nasolabial folds and other areas of the face. Dermatol Surg. 2007 Dec; 33 Suppl 2: p122-126; discussion p126-127.
  • Lemperle G. Foreign body granulomas and their treatment. IMCAS Annual World Congress 2012, Session 30.
  • Lemperle G, Gauthier-Hazan N. Foreign body granulomas after all injectable dermal fillers: part 2. Treatment options. Plast Reconstr Surg. 2009 Jun; 123(6): 1864-1873.
  • Lemperle G, Gauthier-Hazan N, Wolters M et al. Foreign body granulomas after all injectable dermal fillers: part 1. Possible causes. Plast Reconstr Surg. 2009 Jun; 123(6): 1842-1863.